Permanent Senescence Via p16 Leads to Guttae Formation in an In Vitro Human Corneal Endothelial Cell Model

p16介导的永久性衰老导致体外人角膜内皮细胞模型中角膜滴状突起的形成

阅读:2

Abstract

PURPOSE: Fuchs endothelial corneal dystrophy (FECD) is characterized by corneal endothelial cell (CEnC) degeneration and excessive extracellular matrix (ECM) deposition. FECD is an age-related disorder manifested by upregulation of senescence markers. However, the association between senescence and pathological ECM accumulation remains unclear. This study investigated whether senescence mediated cell-cycle arrest drives aberrant ECM deposition and guttae formation in FECD. METHODS: A chronic stress (CS) model was established by concurrently exposing immortalized human CEnCs to ultraviolet-A light (UVA; 25 J/cm2) and 4-hydroxyestradiol (4OHE2; 20 µM) on days 1, 6, and 21, followed by approximately a 60-day recovery period. In vitro guttae were characterized using brightfield microscopy, scanning electron microscopy (SEM), immunofluorescence, and compared with FECD specimens. Cell cycle dynamics, senescence markers, and ECM expression were assessed using flow-cytometry, cell sorting, immunostaining, ELISA, and RT-PCR. RESULTS: In vitro guttae displayed characteristic morphology and ultrastructural similarity to FECD guttae. CS-exposed CEnCs showed significant CDKN2A upregulation (42-fold, P < 0.01) and increased p16 positivity (63 ± 12% vs. 7 ± 3% in controls, P < 0.0001), indicating senescence. Flow cytometry revealed accumulation of CS cells in G0/G1 (74 ± 6% vs. 57 ± 3%, P < 0.0001) phase. G0/G1 sorted p16+ cells exhibited upregulation of COL4A1 (188-fold, P < 0.0001) and LAMB1 (98-fold, P < 0.05). Immunostaining confirmed p16 colocalization with COL4A1 and LAMB1 in CS cells and FECD tissues. ELISA showed elevated levels of TGFBIp in the conditioned media obtained from CS-exposed cells. CONCLUSIONS: G0/G1-arrested p16+ve senescent CEnCs promote pathological ECM deposition and guttae formation. This model, integrating environmental, hormonal, and aging factors, provides a biologically relevant platform for studying FECD and testing therapeutics.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。